These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 31293844)

  • 1. Effect of long-acting aripiprazole monohydrate on inpatient encounters: A retrospective mirror image study.
    Aguilar M; Malcolm B
    Ment Health Clin; 2019 Jul; 9(4):258-262. PubMed ID: 31293844
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical evolution of patients treated with aripiprazole long-acting injectable: a preliminary, prospective, observational study.
    García Álvarez JC; González Sánchez L; García Resa E; Bonete Llácer JM; Román Rodríguez A; Pecino Esquerdo B; Pérez Martínez E
    Int J Psychiatry Clin Pract; 2020 Mar; 24(1):10-17. PubMed ID: 31933402
    [No Abstract]   [Full Text] [Related]  

  • 3. Long-Acting Injectable (LAI) Aripiprazole Formulations in the Treatment of Schizophrenia and Bipolar Disorder: a Systematic Review.
    Rapinesi C; Kotzalidis GD; Mazzarini L; Brugnoli R; Ferracuti S; De Filippis S; Cuomo I; Giordano G; Del Casale A; Angeletti G; Sani G; Girardi P
    Clin Drug Investig; 2019 Aug; 39(8):713-735. PubMed ID: 31152368
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Do Long-Acting Injectable Antipsychotics Prevent or Delay Hospital Readmission?
    Maestri TJ; Mican LM; Rozea H; Barner JC
    Psychopharmacol Bull; 2018 Mar; 48(3):8-15. PubMed ID: 29713100
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative effectiveness of long-acting risperidone in New Zealand: a report of resource utilization and costs in a 12-month mirror-image analysis.
    Carswell C; Wheeler A; Vanderpyl J; Robinson E
    Clin Drug Investig; 2010; 30(11):777-87. PubMed ID: 20712387
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hospitalization Rates and Therapy Costs of German Schizophrenia Patients Who are Initiated on Long-Acting Injectable Medication: A Mirror-Image Study.
    Mahlich J; Olbrich K; Wilk A; Wimmer A; Wolff-Menzler C
    Clin Drug Investig; 2020 Apr; 40(4):355-375. PubMed ID: 32152867
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of Long-Acting Injectable Antipsychotics in Inpatients with Schizophrenia Spectrum Disorder in an Academic Psychiatric Hospital in Switzerland.
    Reymann S; Schoretsanitis G; Egger ST; Mohonko A; Kirschner M; Vetter S; Homan P; Seifritz E; Burrer A
    J Pers Med; 2022 Mar; 12(3):. PubMed ID: 35330441
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcomes comparison of long-acting injectable antipsychotic initiation in treatment-naïve veterans in the inpatient versus outpatient setting.
    Romstadt N; Wonson E
    Ment Health Clin; 2018 Jan; 8(1):24-27. PubMed ID: 29955541
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Real-World Outcomes and Costs Following 6 Months of Treatment with the Long-Acting Injectable (LAI) Aripiprazole Lauroxil for the Treatment of Schizophrenia.
    Lauriello J; Weiden PJ; Gleeson CD; Shah A; Boulanger L; Jariwala-Parikh K; Hedgeman E; O'Sullivan AK
    CNS Drugs; 2021 Oct; 35(10):1123-1135. PubMed ID: 34546558
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identifying Predictors of Primary Adherence to Second Generation Long-Acting Injectable Antipsychotics Following Discharge from an Acute Inpatient Psychiatry Unit.
    Gilbert JL; Nelson LA; Kriz CR; Liu Y; Iuppa CA; Diefenderfer LA; Elliott ESR; Sommi RW
    Psychopharmacol Bull; 2019 Jun; 49(2):8-16. PubMed ID: 31308578
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antipsychotic Adherence and Rehospitalization in Schizophrenia Patients Receiving Oral Versus Long-Acting Injectable Antipsychotics Following Hospital Discharge.
    Marcus SC; Zummo J; Pettit AR; Stoddard J; Doshi JA
    J Manag Care Spec Pharm; 2015 Sep; 21(9):754-68. PubMed ID: 26308223
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Head-to-head comparison of 1-year aripiprazole long-acting injectable (LAI) versus paliperidone LAI in comorbid psychosis and substance use disorder: impact on clinical status, substance craving, and quality of life.
    Cuomo I; Kotzalidis GD; de Persis S; Piacentino D; Perrini F; Amici E; De Filippis S
    Neuropsychiatr Dis Treat; 2018; 14():1645-1656. PubMed ID: 29950846
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment Patterns, Health Care Resource Utilization, and Spending in Medicaid Beneficiaries Initiating Second-generation Long-acting Injectable Agents Versus Oral Atypical Antipsychotics.
    Pilon D; Tandon N; Lafeuille MH; Kamstra R; Emond B; Lefebvre P; Joshi K
    Clin Ther; 2017 Oct; 39(10):1972-1985.e2. PubMed ID: 28919292
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of Long-Acting Injectable Antipsychotics vs Usual Care on Time to First Hospitalization in Early-Phase Schizophrenia: A Randomized Clinical Trial.
    Kane JM; Schooler NR; Marcy P; Correll CU; Achtyes ED; Gibbons RD; Robinson DG
    JAMA Psychiatry; 2020 Dec; 77(12):1217-1224. PubMed ID: 32667636
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-Acting Injectable Antipsychotic Use in Patients with Schizophrenia and Criminal Justice System Encounters.
    Bhatta MP; Bista S; El Khoury AC; Hutzell EG; Tandon N; Smith D
    J Health Econ Outcomes Res; 2021 May; 8(1):63-70. PubMed ID: 34056030
    [No Abstract]   [Full Text] [Related]  

  • 16. "Impact of drug-reimbursement policies on prescribing: A case-study of a newly marketed long-acting injectable antipsychotic among relapsed schizophrenia patients".
    Jackson JW; Fulchino L; Rogers J; Mogun H; Polinski J; Henderson DC; Schneeweiss S; Fischer MA
    Pharmacoepidemiol Drug Saf; 2018 Jan; 27(1):95-104. PubMed ID: 29168261
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment Patterns, Healthcare Resource Utilization and Costs Among Schizophrenia Patients Treated with Long-Acting Injectable Versus Oral Antipsychotics.
    Shah A; Xie L; Kariburyo F; Zhang Q; Gore M
    Adv Ther; 2018 Nov; 35(11):1994-2014. PubMed ID: 30269292
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Medication adherence and discontinuation of long-acting injectable versus oral antipsychotics in patients with schizophrenia or bipolar disorder.
    Greene M; Yan T; Chang E; Hartry A; Touya M; Broder MS
    J Med Econ; 2018 Feb; 21(2):127-134. PubMed ID: 28895758
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Systemic Review and Experts' Consensus for Long-acting Injectable Antipsychotics in Bipolar Disorder.
    Chou YH; Chu PC; Wu SW; Lee JC; Lee YH; Sun IW; Chang CL; Huang CL; Liu IC; Tsai CF; Yen YC
    Clin Psychopharmacol Neurosci; 2015 Aug; 13(2):121-8. PubMed ID: 26243837
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Psychiatric hospitalisation before and after commencing long-acting injectable antipsychotic medication: a mirror-image study.
    Bedggood M; Walton S; Bedggood M
    N Z Med J; 2022 Aug; 135(1560):37-47. PubMed ID: 35999797
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.